AASLD guidelines for the treatment of hepatocellular carcinomaJulie K. Heimbach, Jorge A. Marrero|Hepatology|2017Cited by 4.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJordi Bruix, Josep M. Llovet, Jean‐Luc Raoul et al.|Journal of Hepatology|2012Cited by 821
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON studyJorge A. Marrero, Riccardo Lencioni, Jean-François H. Geschwind et al.|Journal of Hepatology|2016Cited by 385
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?Amit G. Singal, William M. Lee, Mahendra Nehra et al.|The American Journal of Gastroenterology|2013Cited by 227